Notably, RRMS patients had a much greater frequency of the NLRP3 rs3806265 C allele and CC genotype than did relapse patients and healthy controls, but remission patients had a significantly lower frequency, which demonstrated that these modifications in NLRP3-related molecular gene polymorphisms were linked to MS susceptibility [80]. Here, NLRP3 is linked to myeloid sarcoma.